TREATMENT AND PREVENTION OF IMPOTENCE
TREATMENT AND PREVENTION OF IMPOTENCE
批准号:
2144594
负责人:
TOM F LUE
金额:
$20.01万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-01 至 1996-07-31
关键词:
NAD(P)H dehydrogenase RNase protection assay aging amine oxidoreductase cyclic GMP denervation disease /disorder model disease /disorder prevention /control electron microscopy enzyme activity enzyme linked immunosorbent assay gene expression guanylate cyclase immunocytochemistry impotence laboratory rat light microscopy molecular pathology nervous system disorder nervous system regeneration neuroanatomy neurotrophic factors northern blottings penis erection radioimmunoassay
中文摘要
这项研究计划的长期目标是开发最好的
治疗人类勃起功能障碍的策略,
与这种疾病相关的分子机制。 这个的主要目标
该项目旨在阐明阳痿相关的分子机制,
以大鼠为实验动物,
模型 该项目的理由是,阴茎神经损伤和
衰老可能在阳痿中起重要作用,因此了解
这个过程将有助于治疗这种疾病。 这项建议
是基于阴茎神经损伤和衰老相关的假设
阳痿可能是由于非肾上腺素能非胆碱能
血管舒张系统,一氧化氮合酶,鸟苷酸环化酶和环
GMP介导的机制。 这一假设将通过
追求以下具体目标:1)调查的作用
阴茎神经损伤和衰老对非肾上腺素能、非胆碱能
血管扩张系统与勃起功能障碍有关。 这
目的将通过检查阴茎神经的神经解剖学来实现
通过NADPH黄递酶(一氧化氮合酶)使用免疫组织化学,
光学和电子显微镜。 2)为了阐明
与神经损伤和衰老介导的阳痿有关。 这
通过测定一氧化氮合酶活性,
(酶法),免疫组织化学),一氧化氮基因表达
(北方印迹,RNA酶保护试验),鸟苷酸环化酶,和环
GMP。 3)探讨神经生长因子在再生中的作用
非肾上腺素能非胆碱能神经的损伤。 这一目标
将通过切除海绵体神经和慢性
通过植入的渗透泵施用神经生长因子。 的
用一氧化氮合酶检测神经再生过程
染色和光学和电子显微镜检查。 完成这些
实验将清楚地阐明阳痿的分子机制
与阴茎神经损伤和衰老有关。 该提案还将
探讨神经生长因子在海绵体神经再生中的作用
这可能有助于治疗勃起功能障碍相关的
神经损伤
英文摘要
The long-term objective of this research proposal is to develop the best
strategy for treating human erectile dysfunction by understanding the
molecular mechanisms associated with this disease. The main goal of this
project is to elucidate the molecular mechanisms of impotence associated
with penile nerve injury and aging, using rats as an experimental animal
model. The rational for this project is that penile nerve injury and
aging may play an important role in impotence and therefore understanding
of this process will help in treatment of this disease. This proposal
is based on the hypothesis that penile nerve injury and aging associated
impotence may be due to alteration in nonadrenergic noncholinergic
vasodilator system, nitric oxide synthase, guanylate cyclase and cyclic
GMP mediated mechanisms. This hypothesis will be achieved through
pursuit of the following specific aims: 1) To investigate the role of
penile neural injury and aging on nonadrengergic, noncholinergic
vasodilator system which is associated with erectile dysfunction. This
objective will be achieved by examining the neuroanatomy of penile nerves
by NADPH diaphorase (nitric oxide synthase) using immunohistochemistry,
light and electron microscopy. 2) To elucidate the molecular mechanisms
associated with nerve injury and aging mediated impotence. This
objective will be achieved by determining nitric oxide synthase activity
(enzymatic assay), immunohistochemistry), nitric oxide gene expression
(Northern blot, RNase protection assay), guanylate cyclase, and cyclic
GMP. 3) To investigate the role of nerve growth factor in regeneration
of nonadrenergic noncholinergic nerves after neurotomy. This objective
will be achieved by denervating cavernous nerves and chronic
administration of nerve growth factor by an implanted osmotic pump. The
nerve regeneration process will be examined by nitric oxide synthase
staining and light and electron microscopy. The accomplishment of these
experiments will clearly elucidate the molecular mechanisms of impotence
associated with penile nerve injury and aging. This proposal will also
investigate the nerve growth factor in regeneration of cavernous nerves
which might help in treatment of erectile dysfunction associated with
nerve injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regenerative therapy for stress urinary incontinence and pelvic floor disorder
-
批准号:10370405
-
项目类别:
-
资助金额:$56.88万
-
财政年份:2020
-
负责人:TOM F LUE
-
依托单位:
Regenerative therapy for stress urinary incontinence and pelvic floor disorder
-
批准号:10600104
-
项目类别:
-
资助金额:$56.88万
-
财政年份:2020
-
负责人:TOM F LUE
-
依托单位:
Therapy for Obesity-associated Stress Urinary Incontinence
-
批准号:9107289
-
项目类别:
-
资助金额:$66.73万
-
财政年份:2016
-
负责人:TOM F LUE
-
依托单位:
Therapy for Obesity-associated Stress Urinary Incontinence
-
批准号:9129211
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2015
-
负责人:TOM F LUE
-
依托单位:
Mechanism and Prevention of Female Stress Urinary Incontinence
-
批准号:8531905
-
项目类别:
-
资助金额:$36.91万
-
财政年份:2005
-
负责人:TOM F LUE
-
依托单位:
Mechanism and Prevention of Female Stress Urinary Incontinence
-
批准号:8039297
-
项目类别:
-
资助金额:$49.21万
-
财政年份:2005
-
负责人:TOM F LUE
-
依托单位:
Hormones and Female Urinary Incontinence
-
批准号:6858358
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2005
-
负责人:TOM F LUE
-
依托单位:
Hormones and Female Urinary Incontinence
-
批准号:7030208
-
项目类别:
-
资助金额:$30.33万
-
财政年份:2005
-
负责人:TOM F LUE
-
依托单位:
Mechanism and Prevention of Female Stress Urinary Incontinence
-
批准号:8300243
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2005
-
负责人:TOM F LUE
-
依托单位:
Hormones and Female Urinary Incontinence
-
批准号:7215248
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2005
-
负责人:TOM F LUE
-
依托单位:
Hormones and Female Urinary Incontinence
-
批准号:7586849
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2005
-
负责人:TOM F LUE
-
依托单位:
Hormones and Female Urinary Incontinence
-
批准号:7368081
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2005
-
负责人:TOM F LUE
-
依托单位:
Mechanism and Prevention of Female Stress Urinary Incontinence
-
批准号:8146097
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2005
-
负责人:TOM F LUE
-
依托单位:
MOLECULAR MECHANISM FEMALE STRESS URINARY INCONTINENCE
-
批准号:2743700
-
项目类别:
-
资助金额:$25.83万
-
财政年份:1996
-
负责人:TOM F LUE
-
依托单位:
MOLECULAR MECHANISM FEMALE STRESS URINARY INCONTINENCE
-
批准号:6329405
-
项目类别:
-
资助金额:$32.44万
-
财政年份:1996
-
负责人:TOM F LUE
-
依托单位:
MOLECULAR MECHANISM FEMALE STRESS URINARY INCONTINENCE
-
批准号:6476234
-
项目类别:
-
资助金额:$27.23万
-
财政年份:1996
-
负责人:TOM F LUE
-
依托单位:
MOLECULAR MECHANISM FEMALE STRESS URINARY INCONTINENCE
-
批准号:6124808
-
项目类别:
-
资助金额:$31.6万
-
财政年份:1996
-
负责人:TOM F LUE
-
依托单位:
PATHOPHYSIOLOGY OF FEMALE STRESS URINARY INCONTINENCE
-
批准号:2331481
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:TOM F LUE
-
依托单位:
Prevention and Treatment of Impotence
-
批准号:8044701
-
项目类别:
-
资助金额:$36.37万
-
财政年份:1994
-
负责人:TOM F LUE
-
依托单位:
Prevention and Treatment of Impotence
-
批准号:7172676
-
项目类别:
-
资助金额:$33.76万
-
财政年份:1994
-
负责人:TOM F LUE
-
依托单位:
海外基金